Swiss DolorClast ® Brochure - Ortho Providers

“
The Weil Foot & Ankle Institute has been involved with Extracorporeal
Shockwave Therapy (ESWT) since 2000 and was the first group in the USA
to publish the results of this treatment for plantar fasciosis. Since that time,
I have been the principal investigator on three FDA studies using different
ESWT technologies (electrohydraulic, piezoelectric, and pneumatic technology
– Swiss DolorClast ® ). Much to our surprise, the double blinded results of the Swiss
DolorClast ® superseded the results of the other two technologies while offering
a tolerable treatment, over three sessions, without the use of sedation or even local anesthetic.
We believe that ESWT with the Swiss DolorClast ® will be an important addition to treatment
of the podiatric, orthopaedic, and sports medicine patients. ”
“
We had excellent experiences with the Swiss DolorClast ® , and I can fully recommend it. It is a
valuable part of a modern treatment concept. Through(out) our international network, we have treated
many professional athletes, and in no time they were all back in the game thanks to this non-invasive and
gentle treatment.
The medical community has only just begun to discover the possibilities of this treatment. ”
“
The Institute of Biomechanics and Orthopaedics of the German Sport
University Cologne has been working with Extracorporeal Shockwaves Therapy
(ESWT) for several years, with respect to clinical applications as well as basic
research concerning its effects on a cellular level.
During my personal experience with the Swiss DolorClast ® as the attending
medical professional of ATP tennis players, I have observed an increased relevance
of this therapy in the field of sports medicine and in the care of professional athletes.
Based on our clinical application and various experimental research projects, extracorporeal
shockwaves seem to be a successful and simple form of therapy for orthopaedic disorders. ”